Bionano Genomics Cash from Financing (Quarterly) Insights

Bionano Genomics Inc (BNGO)

0.9585 +0.08 (+8.54%) USD | NASDAQ | May 01, 16:00

0.99 +0.03 (+3.29%) After-Hours: 05:08

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	68.48M
September 30, 2023	12.59M
June 30, 2023	17.88M
March 31, 2023	14.86M
December 31, 2022	0.146M
September 30, 2022	22.65M
June 30, 2022	0.203M
March 31, 2022	0.007M
December 31, 2021	1.967M
September 30, 2021	13.77M
June 30, 2021	-17.16M
March 31, 2021	337.54M
December 31, 2020	31.69M
September 30, 2020	15.08M

Date	Value
June 30, 2020	16.27M
March 31, 2020	-1.135M
December 31, 2019	18.49M
September 30, 2019	0.218M
June 30, 2019	0.811M
March 31, 2019	10.86M
December 31, 2018	-0.0323M
September 30, 2018	19.26M
June 30, 2018	3.216M
March 31, 2018	13.33M
December 31, 2017	1.475M
September 30, 2017	2.901M
June 30, 2017	6.257M
March 31, 2017	6.975M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-17.16M

Minimum

Jun 2021

337.54M

Maximum

Mar 2021

29.18M

Average

13.77M

Median

Sep 2021

Cash from Financing (Quarterly) Benchmarks

Bruker Corp	-59.90M
Azenta Inc	-113.15M
Harvard Bioscience Inc	-4.116M
Akoya Biosciences Inc	11.08M
Singular Genomics Systems Inc	0.072M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-29.78M
Cash from Investing (Quarterly)	-55.37M
Free Cash Flow	-126.87M
Free Cash Flow Per Share (Quarterly)	-0.7657
Free Cash Flow to Equity (Quarterly)	-100.33M
Free Cash Flow to Firm (Quarterly)	-26.82M
Free Cash Flow Yield	-489.3%